Sign In
Buy SDGR
$14.93
-0.0100 (-0.0669%)
At Close: Jun 03, 2026
Schrodinger: Attractive Risk-Reward
12:36pm, Monday, 06'th Nov 2023
Customers in the biopharma industry are cutting spending, creating a soft demand environment for Schrodinger's software and drug discovery services. Despite the recent share price spike, Schrodinger's
3 Top Publicly Traded Companies Leading the AI Revolution
09:00am, Saturday, 04'th Nov 2023
Better-than-expected labor productivity data for the U.S. economy reported on Nov. 2 was the reason behind the huge stock market rally that day. “Non-farm productivity, which measures hourly output
Is Schrödinger Stock a Buy Now?
08:15am, Thursday, 02'nd Nov 2023
Schrödinger helps drugmakers discover high-quality leads for drug development. It has a star-studded cast of collaborators already, but it isn't growing much.
Schrödinger, Inc. (SDGR) Q3 2023 Earnings Call Transcript
10:36pm, Wednesday, 01'st Nov 2023
Schrödinger, Inc. (NASDAQ:SDGR ) Q3 2023 Results Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Commu
3 Bill Gates Stocks to Buy for Billionaire-Like Returns
12:31pm, Friday, 27'th Oct 2023
When investors think of Bill Gates stocks, they inevitably come up with Microsoft (NASDAQ: MSFT ), the software company he co-founded with Paul Allen in 1975 in Albuquerque. However, as Gates has spen
This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest?
06:50am, Wednesday, 25'th Oct 2023
Schrödinger has a physics-based platform that helps accelerate drug discovery. The company sells its software to other businesses and has its own drug pipeline.
Why Wall Street Thinks This Artificial Intelligence (AI) Stock Could Skyrocket 140% Over the Next 12 Months
05:50am, Monday, 16'th Oct 2023
This company uses AI to improve drug discovery for all of the 20 biggest biopharmaceutical companies. Even the most pessimistic analyst thinks the stock could jump nearly 32% over the next 12 months.
3 Artificial Intelligence Stocks That Could Outperform the ‘Godfather of AI'
02:46pm, Monday, 09'th Oct 2023
I don't think there is any debate on the point that Nvidia (NASDAQ: NVDA ) has established itself as the godfather of AI. As growth accelerates for Nvidia in a big addressable global market, the compa
7 Trailblazing AI Stocks to Buy on Any Weakness
07:19pm, Sunday, 08'th Oct 2023
The transformative power of artificial intelligence ( AI ) — with regards to drug makers and banks to oil companies to every firm that carries out intensive sales activities — is widely known. Ye
Schrodinger: Leading The AI Healthcare Revolution
03:49am, Friday, 29'th Sep 2023
Schrödinger is a leading AI drug discovery company with a comprehensive platform used by researchers and scientists worldwide. The company's flagship product, Maestro, integrates various proprietary
The Good And Bad: Allison Transmission & Schrodinger Inc.
02:32pm, Thursday, 21'st Sep 2023
See two of the featured stocks from this month's model portfolios.
Schrodinger: More Than An AI Bubble Stock
11:10pm, Saturday, 02'nd Sep 2023
Schrodinger's stock has performed well this year due to AI hype and strength in its drug discovery business. While the company appears attractively valued from a long-term perspective, the tight finan
7 Stocks the Big Money Is Buying Now
10:07pm, Tuesday, 29'th Aug 2023
There's no foolproof method for making money in the stock market, and, in my view, no one should rely on any one technique for picking stocks. After all, using multiple criteria — including analyzin
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
07:42pm, Wednesday, 23'rd Aug 2023
Artificial intelligence is changing the drug-discovery process by making it much faster and cheaper. Traditionally, most biotech stock drug candidates fail.
3 AI Stocks Billionaires Are Loading Up On
06:00am, Friday, 04'th Aug 2023
Many investors, including a significant number of very wealthy individuals and institutions, are becoming enthralled with AI stocks. According to Goldman Sachs (NYSE: GS ), up to $200 billion could be
